Graf Akcie GTHP (Guided Therapeutics, Inc.). Diskuze k akciím GTHP. Aktuální informace GTHP.

Základní informace o společnosti Guided Therapeutics, Inc. (Akcie GTHP)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 7.98M
Hodnota podniku (EV) 16.97M
Tržby 104.000k
EBITDA -1.03
Zisk 1.777M
Růst v tržbách Q/Q -25.00 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 4.00
Forward P/E N/A
EV/Sales 163.21
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 75.86
P/FCF N/A
Price/Book -0.73
Účetní hodnota na akcii -0.74
Hotovost na akcii 0.07
FCF vůči ceně -24.57 %
Počet zaměstnanců 5
Tržba na zaměstnance N/A
Profit margin -280.00 %
Operating margin -1,809.62 %
Gross margin 140.00 %
EBIT margin N/A %
EBITDA margin -991.35 %
EPS - Zisk na akcii 0.14
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets -78.18 %
Return on equity N/A %
ROIC 253.77 %
ROCE 0.00 %
Dluhy/Equity -1.12
Čistý dluh/EBITDA -9.31
Current ratio 0.29
Quick Ratio 0.18
Volatilita 13.71
Beta 0.78
RSI 47.31
Cílová cena analytiků 0
Známka akcie (dle analytiků) N/A
Insider ownership 53.11 %
Institutional ownership 3.77 %
Počet akcií 13.297M
Procento shortovaných akcií 0.00 %
Short ratio 0.00 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1997
Země United States

Finanční výsledky akcie GTHP

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.036$0.057$0.244$0.605$0.606$0.823
Cost Of Goods Sold$0.07$0.089$0.53$0.493$0.537$0.891
Gross Profit$-0.034$-0.032$-0.286$0.112$0.069$-0.068
Research And Development Expenses$0.122$0.244$0.334$0.733$1.477$2.788
SG&A Expenses$0.781$1.272$2.501$3.199$4.819$5.813
Other Operating Income Or Expenses------
Operating Expenses$0.973$1.605$3.365$4.425$6.833$9.492
Operating Income$-0.937$-1.548$-3.121$-3.82$-6.227$-8.669
Total Non-Operating Income/Expense$-0.984$2.564$-7.575$-0.15$-0.675$-1.214
Pre-Tax Income$-1.921$1.016$-10.696$-3.97$-6.902$-9.883
Income Taxes------
Income After Taxes$-1.921$1.016$-10.696$-3.97$-6.902$-9.883
Other Income------
Income From Continuous Operations$-1.921$1.016$-10.696$-3.97$-6.902$-9.883
Income From Discontinued Operations------
Net Income$-1.921$0.9$-10.974$-4.995$-9.503$-10.035
EBITDA$-0.719$-0.686$-2.908$-2.597$-5.173$-7.429
EBIT$-0.937$-1.548$-3.121$-3.82$-6.227$-8.669
Basic Shares Outstanding3000-1
Shares Outstanding36500-1
Basic EPS$-0.58$1.95$997.64$-20516.67$-4949483.00$-13.02
EPS - Earnings Per Share$-0.58$0.01$997.64$-20516.67$-4949483.00$-13.02
# 2020 2019 2018 2017 2016 2015
Current Ratio0.0830.01780.02510.1120.38820.3865
Long-term Debt / Capital-0.0357-0.022----0.226
Debt/Equity Ratio-0.3476-0.3221-0.2393-0.4354-0.2738-0.5944
Gross Margin-94.4445-56.1404-117.213118.512411.3861-8.2625
Operating Margin-2602.778-2715.789-1279.098-631.405-1027.558-1053.341
EBIT Margin-2602.778-2715.789-1279.098-631.405-1027.558-1053.341
EBITDA Margin-1997.222-1203.509-1191.803-429.2562-853.6304-902.6732
Pre-Tax Profit Margin-5336.1111782.456-4383.607-656.1983-1138.944-1200.851
Net Profit Margin-5336.1111578.947-4497.541-825.6198-1568.152-1219.32
Asset Turnover0.03050.24150.6010.40550.2410.2715
Inventory Turnover Ratio1.45830.78072.91210.63780.47990.7551
Receiveable Turnover2.76924.384681.3333-3.18952.4349
Days Sales In Receivables131.805683.24564.4877-114.4389149.9028
ROE - Return On Equity10.828-6.109452.282737.566290.6488192.1643
Return On Tangible Equity11.3434-6.420655.128342.8448124.0921221.3438
ROA - Return On Assets-162.7966430.5085-2634.483-266.0858-274.4334-326.064
ROI - Return On Investment11.7485-6.561655.128342.8448124.0921271.3619
Book Value Per Share-5.1024-5.8629-312.9355-13.8644-1855.856-4.6078
Operating Cash Flow Per Share-0.2232103.9791-95.11432014.6373-2015.3738-8.0649
Free Cash Flow Per Share-0.2232103.9791-95.11432018.6413-2019.1833-8.2577